Chemoinformaics analysis of 2,6-Dimethoxy-1,4-benzoquinone
Molecular Weight | 168.148 | nRot | 2 |
Heavy Atom Molecular Weight | 160.084 | nRig | 8 |
Exact Molecular Weight | 168.042 | nRing | 1 |
Solubility: LogS | -1.976 | nHRing | 0 |
Solubility: LogP | 0.006 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 21.9023 |
nHD | 0 | BPOL | 13.2337 |
QED | 0.552 |
Synth | 2.52 |
Natural Product Likeliness | 1.349 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.166 |
Pgp-sub | 0.001 |
HIA | 0.009 |
CACO-2 | -4.454 |
MDCK | 0.0000246 |
BBB | 0.265 |
PPB | 0.840085 |
VDSS | 0.938 |
FU | 0.0645887 |
CYP1A2-inh | 0.932 |
CYP1A2-sub | 0.896 |
CYP2c19-inh | 0.572 |
CYP2c19-sub | 0.758 |
CYP2c9-inh | 0.116 |
CYP2c9-sub | 0.129 |
CYP2d6-inh | 0.159 |
CYP2d6-sub | 0.179 |
CYP3a4-inh | 0.012 |
CYP3a4-sub | 0.266 |
CL | 5.793 |
T12 | 0.83 |
hERG | 0.004 |
Ames | 0.685 |
ROA | 0.822 |
SkinSen | 0.96 |
Carcinogencity | 0.835 |
EI | 0.973 |
Respiratory | 0.877 |
NR-Aromatase | 0.237 |
Antiviral | No |
Prediction | 0.904174 |